Cell Death Discovery (May 2021)

Single cell RNA sequencing for breast cancer: present and future

  • Lili Ren,
  • Junyi Li,
  • Chuhan Wang,
  • Zheqi Lou,
  • Shuangshu Gao,
  • Lingyu Zhao,
  • Shuoshuo Wang,
  • Anita Chaulagain,
  • Minghui Zhang,
  • Xiaobo Li,
  • Jing Tang

DOI
https://doi.org/10.1038/s41420-021-00485-1
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Breast cancer is one of the most common malignant tumors in women. It is a heterogeneous disease related to genetic and environmental factors. Presently, the treatment of breast cancer still faces challenges due to recurrence and metastasis. The emergence of single-cell RNA sequencing (scRNA-seq) technology has brought new strategies to deeply understand the biological behaviors of breast cancer. By analyzing cell phenotypes and transcriptome differences at the single-cell level, scRNA-seq reveals the heterogeneity, dynamic growth and differentiation process of cells. This review summarizes the application of scRNA-seq technology in breast cancer research, such as in studies on cell heterogeneity, cancer cell metastasis, drug resistance, and prognosis. scRNA-seq technology is of great significance to deeply analyze the mechanism of breast cancer occurrence and development, identify new therapeutic targets and develop new therapeutic approaches for breast cancer.